Journal of Clinical Oncology, Vol 23, No 26 (September 10), 2005: pp. 6370-6378
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.05.011
Molecular Pathogenesis of Mucosa-Associated Lymphoid Tissue Lymphoma
Pedro Farinha,
Randy D. Gascoyne
From the British Columbia Cancer Agency and the University of British Columbia Department of Pathology, Vancouver, British Columbia, Canada
Address reprint requests to Randy D. Gascoyne, MD, Department of Pathology, British Columbia Cancer Agency, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada; e-mail: rgascoyn{at}bccancer.bc.ca.
Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (MALT) type occur in a number of anatomic sites, but share overlapping morphologic and immunophenotypic features. Helicobacter pylori infection has been identified as an etiologic factor in gastric MALT lymphoma, and a growing list of other infectious organisms have recently been shown to be associated with MALT lymphomas at other anatomic sites. Although cause and effect has not been established for most of these infectious agents, our understanding of the biology has significantly improved, in part through the application of standard cytogenetic analyses. The common karyotypic alterations that characterize MALT lymphomas include the trisomies 3 and 18, the translocations t(11;18)(q21;q21), t(1;14)(p22;q32), t(14;18)(q32;q21), t(3;14)(q27;q32), and the recently described t(3;14)(p14.1;q32). This apparent complexity of cytogenetic alterations that have now been implicated in the pathogenesis of extranodal MALT lymphoma serves as a paradigm for molecular cross talk in neoplastic disease. Recent data have shown that at least three of the disparate translocations affect a common signaling mechanism, and thus unify all three under a common pathogenesis, resulting in the constitutive activation of the nuclear factor kappa B (NF- B) pathway. It may be that the new MALT-related translocation involving the FOXP1 gene and other as yet undiscovered translocations may all have in common increased NF- B signaling.
Supported in part by a grant from the Canadian Institutes of Health Research (CIHR STP-53912); Fundacao para a Ciencia e a Tecnologia (BD 13230/2003); and support of the molecular pathology training program at the British Columbia Cancer Agency by Berlex US (Montville, NJ), Berlex Canada (Pointe-Claire, Quebec, Canada) and Schering (Montville, NJ).
Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Novak, A. Rinaldi, I. Kwee, S. V. Nandula, P. M. V. Rancoita, M. Compagno, M. Cerri, D. Rossi, V. V. Murty, E. Zucca, et al.
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Blood,
May 14, 2009;
113(20):
4918 - 4921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Chng, E. D. Remstein, R. Fonseca, P. L. Bergsagel, J. A. Vrana, P. J. Kurtin, and A. Dogan
Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications
Blood,
January 15, 2009;
113(3):
635 - 645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Psyrri, S. Papageorgiou, and T. Economopoulos
Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management
Ann. Onc.,
December 1, 2008;
19(12):
1992 - 1999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Vinatzer, M. Gollinger, L. Mullauer, M. Raderer, A. Chott, and B. Streubel
Mucosa-Associated Lymphoid Tissue Lymphoma: Novel Translocations Including Rearrangements of ODZ2, JMJD2C, and CNN3
Clin. Cancer Res.,
October 15, 2008;
14(20):
6426 - 6431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wohrer, M. Troch, B. Streubel, M. Hoffmann, L. Mullauer, A. Chott, and M. Raderer
Pathology and clinical course of MALT lymphoma with plasmacytic differentiation
Ann. Onc.,
December 1, 2007;
18(12):
2020 - 2024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Morton, J. J. Turner, J. R. Cerhan, M. S. Linet, P. A. Treseler, C. A. Clarke, A. Jack, W. Cozen, M. Maynadie, J. J. Spinelli, et al.
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Blood,
July 15, 2007;
110(2):
695 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Glocker, C. Bogdan, and M. Kist
Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany
J. Antimicrob. Chemother.,
May 1, 2007;
59(5):
874 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Crosetto, M. Bienko, and I. Dikic
Ubiquitin Hubs in Oncogenic Networks
Mol. Cancer Res.,
December 1, 2006;
4(12):
899 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-W. Chen, X.-T. Hu, A. C. Liang, W.-Y. Au, C.-C. So, M. L. Wong, L. Shen, Q. Tao, K.-M. Chu, Y.-L. Kwong, et al.
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma
Blood,
October 1, 2006;
108(7):
2373 - 2383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Suarez, O. Lortholary, O. Hermine, and M. Lecuit
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
Blood,
April 15, 2006;
107(8):
3034 - 3044.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|